These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23686056)

  • 1. Successful use of paliperidone in a clozapine-resistant schizophrenic patient.
    Hsieh TH; Liu CT
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E36. PubMed ID: 23686056
    [No Abstract]   [Full Text] [Related]  

  • 2. Paliperidone palmitate for refractory and clozapine-resistant schizophrenia.
    Maia-de-Oliveira JP; Nunes EA; Ushirohira JM; Machado-de-Sousa JP; Bressan RA; Hallak JE
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e14-6. PubMed ID: 25716490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using paliperidone as a monotherapeutic agent on a schizophrenic patient with cirrhosis of the liver.
    Chou HW; Chen CL
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E37. PubMed ID: 23487226
    [No Abstract]   [Full Text] [Related]  

  • 4. Remission of drug-induced hepatitis after switching from risperidone to paliperidone.
    Paulzen M; Orfanos S; Gründer G
    Am J Psychiatry; 2010 Mar; 167(3):351-2. PubMed ID: 20194492
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvements in micturition and urinary retention after switching from amisulpiride to paliperidone in a schizophrenic patient.
    Lai CH
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E11-2. PubMed ID: 23224462
    [No Abstract]   [Full Text] [Related]  

  • 6. Paliperidone as an alternative for risperidone in a case of schizophrenia with retrograde ejaculation.
    Kandasamy A
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E17-8. PubMed ID: 23037663
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of oral dyskinesia after switching from aripiprazole to paliperidone: a case report.
    Lai CH
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):E18. PubMed ID: 21948908
    [No Abstract]   [Full Text] [Related]  

  • 8. Paliperidone: An improvement over risperidone?
    Dopheide JA
    Am J Health Syst Pharm; 2008 Mar; 65(5):401. PubMed ID: 18281730
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating residual insomnia in schizophrenia: examining the options.
    Andrade C; Suresh Kumar PN
    Acta Psychiatr Scand; 2013 Jan; 127(1):11. PubMed ID: 23240596
    [No Abstract]   [Full Text] [Related]  

  • 10. Paliperidone overdose in a patient with schizophrenia.
    Chang JP; Huang CC; Su KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):418. PubMed ID: 19995588
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy, tolerability and safety of paliperidone extended-release in the treatment of schizophrenia and schizoaffective disorder].
    Bellantuono C; Santone G
    Riv Psichiatr; 2012; 47(1):5-20. PubMed ID: 22358213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible neuroleptic malignant syndrome associated with paliperidone.
    Duggal HS
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):477-8. PubMed ID: 18070861
    [No Abstract]   [Full Text] [Related]  

  • 13. Practical guidelines on the use of paliperidone palmitate in schizophrenia.
    Newton R; Hustig H; Lakshmana R; Lee J; Motamarri B; Norrie P; Parker R; Schreiner A
    Curr Med Res Opin; 2012 Apr; 28(4):559-67. PubMed ID: 22321007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paliperidone in the treatment of Tourette's syndrome with comorbid schizophrenia.
    Guan CH; Tsai SJ
    Psychiatry Clin Neurosci; 2013 Feb; 67(2):128. PubMed ID: 23438169
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.
    Canuso CM; Dirks B; Carothers J; Kosik-Gonzalez C; Bossie CA; Zhu Y; Damaraju CV; Kalali AH; Mahmoud R
    Am J Psychiatry; 2009 Jun; 166(6):691-701. PubMed ID: 19411369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paliperidone].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Aug; 29(8):280-2. PubMed ID: 16927595
    [No Abstract]   [Full Text] [Related]  

  • 17. Paliperidone for irritability in autistic disorder.
    Stigler KA; Erickson CA; Mullett JE; Posey DJ; McDougle CJ
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):75-8. PubMed ID: 20166801
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerability of paliperidone: a meta-analysis of randomized, controlled trials.
    Harrington CA; English C
    Int Clin Psychopharmacol; 2010 Nov; 25(6):334-41. PubMed ID: 20706126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.
    Jones A
    J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with paliperidone extended-release tablets in a case of resistant undifferentiated schizophrenia: clinical improvement with 12 mg and evaluation through 3TRE scale].
    Rusconi AC; Carlone C; Muscillo M; Piccione M
    Riv Psichiatr; 2009; 44(4):267-72. PubMed ID: 20066799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.